JP Morgan Chase
PCRX icon

JP Morgan Chase’s Pacira BioSciences PCRX Stock Holding History

JP Morgan Chase’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-75,000
Closed -$3.94M – 5689
2020
Q2 		$3.94M Buy
+75,000
New +$3.13M ﹤0.01% 2637
2018
Q4 		– Sell
-13,500
Closed -$664K – 5865
2018
Q3 		$664K Sell
13,500
-176,500
-93% -$7.63M ﹤0.01% 4139
2018
Q2 		$6.09M Buy
+190,000
New +$6.56M ﹤0.01% 2528
2017
Q3 		– Sell
-100,000
Closed -$4.77M – 5121
2017
Q2 		$4.77M Buy
+100,000
New +$4.64M ﹤0.01% 2504

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase's PCRX Position: Q2 2026 in Review

JP Morgan Chase increased its Pacira BioSciences (PCRX) stake by 44% in Q2 2026, buying an estimated $2.51M and bringing the position to 346,697 shares worth $8.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2930.

JP Morgan Chase first reported a position in PCRX in Q2 2013 and has held it in 53 quarters since. The position peaked at $31.9M in Q2 2014. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • JP Morgan Chase held 346,697 shares of Pacira BioSciences worth $8.7M as of Q2 2026.
  • JP Morgan Chase bought 106,328 Pacira BioSciences shares in Q2 2026, an estimated $2.51M.
  • Pacira BioSciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2930 holding.
  • JP Morgan Chase first reported a position in Pacira BioSciences in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Pacira BioSciences position peaked at $31.9M in Q2 2014.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.